Lower muscle volume, and more fat stored in the muscle, are seen linked to higher risk for disease and comorbidities.

With new systemic treatments now available for psoriatic disease, questions remain on the comparable efficacy and safety of these therapies.

The exact cause of psoriatic arthritis isn't known, but the immune system plays a major role in its development. In general, a person will develop psoriatic arthritis when they have a genetic ...

Researchers have found in a new research that deucravacitinib significantly improves joint pain and musculoskeletal symptoms ...

Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.

Understand how psoriatic arthritis increases heart disease risk through inflammation. Learn management tips for heart health, from lifestyle changes to medication discussions.

In July 2025, Janssen Research & Development LLC conducted a study is to evaluate the efficacy of icotrokinra compared to ...

Many people with psoriatic arthritis will experience symptoms in their feet. This can lead to swollen toes, pitted nails, ...

Psoriatic arthritis is a condition in which the immune system attacks the joints and causes inflammation. The following symptoms may occur in the fingers, toes, knees, or other areas.

IL-17 inhibitors are approved for axial spondyloarthritis and psoriatic arthritis, but their effectiveness in heavily ...

Until recently, little was known about psoriatic arthritis (PsA), a disease first described and classified by the medical community in the 1970s. A 2008 Belgian study offered hope to people with ...

Many people with psoriatic arthritis take medications to manage their symptoms, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs) and biologics.